Dr. Gönen has been at MSK since 1999 and has been serving as Chief of the Biostatistics Service since 2015. His translational and clinical collaborations focus on surgical treatment of gastrointestinal and hepatobiliary cancers, response evaluation and imaging endpoints for clinical trials and biomarker development. Most of Dr. Gönen’s methodological research originates from these collaborations, including building, assessing and comparing prognostic and predictive models, design and analysis of clinical trials and imaging studies, as well as Bayesian methods. He is a recent awardee of the Foundation for NIH to study alternative response metrics in cancer clinical trials and the author of a book on the use of receiver operating characteristic curves using SAS®. Dr. Gönen served a co-director of the AACR/ASCO Vail Workshop on Methods in Clinical Cancer Research from 2011 to 2013 and was a member of ASCO’s Cancer Research Committee from 2012 to 2014. He has been serving the Society for Clinical Trials (SCT) in various roles: Program Chair for the 2012 Annual Meeting, deputy editor of Clinical Trials: Journal of the Society for Clinical Trials, member of the board of directors, member of the executive committee and, most recently, as President-Elect. Dr. Gönen is a fellow of the American Statistical Association (ASA), a fellow of the SCT, and a member of the board of reviewing editors for Science in Translational Medicine. He served the International Biometric Society as the Program Chair for its North America meeting in 2015.